Results 161 to 170 of about 23,600 (247)

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study. [PDF]

JCO Clin Cancer Inform
Vanderkerken M, Van Eygen K, Galle V, Verbiest A, Janssens A, Masuy I, Theys K, Cuppens T, Muylle K, De Becker A.   +9 more
europepmc   +1 more source

Next-generation Bruton's tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report. [PDF]

Ann Hematol
Chen L, Huang Y, Xu J, Huang S, Zhang Q, Hua F, Pan X, Mi JQ.   +7 more
europepmc   +1 more source

Gamma Heavy-Chain Disease Presenting with Hypercalcaemia and Ascites. [PDF]

Eur J Case Rep Intern Med
El Boutahiri I, Mrad K, Lionne P, Terriou L.   +3 more
europepmc   +1 more source

Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population. [PDF]

Hemasphere
Ghia P, Ysebaert L, Janssens A, Stilgenbauer S, Fouad M, Schioppa CA, Hernández-Rivas JÁ, Tedeschi A.   +7 more
europepmc   +1 more source

Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506. [PDF]

Mol Ther Oncol
Schuitmaker L, van der Wiel AMA, Lieuwes NG, Biemans R, Mutsters NAM, Jung J, Bastos VC, Sagarra ÈP, Kuang S, Setton J, Langie SAS, Kampen KR, Theys J, Yaromina A, Dubois LJ, Lambin P.   +15 more
europepmc   +1 more source

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report. [PDF]

Front Oncol
Lv Z, Lu P, Jing C, Yi X, Wu X.
europepmc   +1 more source

Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment. [PDF]

Mediterr J Hematol Infect Dis
Sachanas S, Vassilakopoulos T, Angelopoulou M, Papageorgiou S, Spanoudakis E, Bouzani M, Dimou M, Panagiotidis P.   +7 more
europepmc   +1 more source

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia [PDF]

, 2015
Bartlett, N. L, et al,
core   +1 more source

Frequency, distribution, and prognostic impact of metastatic site in dogs with splenic hemangiosarcoma. [PDF]

J Vet Intern Med
Valenti P, Bacci B, Catalucci C, Treggiari E, Bianchi ML, Capra G, Avallone G.   +6 more
europepmc   +1 more source

A Rare Case of Chronic Lymphocytic Leukemia Complicated by Myasthenia Gravis. [PDF]

J Community Hosp Intern Med Perspect
Khan E, Ilyas R, Shah S, Jiwani R, Samhouri Y, Khan C.   +5 more
europepmc   +1 more source